K-numberK250746
Device nameMagnetic Surgical System
ApplicantLevita Magnetics International Corp
Product codePNL
Device classClass II
Decision dateJun 7, 2025
DecisionSubstantially Equivalent
Regulation878.4815
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Levita Magnetic Surgical System is a minimally invasive surgical device comprising a disposable magnetic grasper and a reusable external magnetic controller. It grasps and retracts soft tissues and organs (gallbladder, liver, diaphragm, prostate, colon) during laparoscopic and open procedures to improve visualization. The device is indicated for patients with BMI 20–60 kg/m², including a new 12.5 cm grasper tip for diaphragm retraction in bariatric and hiatal hernia surgery.

Technological characteristics

The modified magnetic grasper incorporates minor changes to materials and manufacturing processes, with shelf life extended from 6 months to 12 months. A new 12.5 cm detachable grasper tip (previously 6.5 cm) enables reach to deeper anatomical structures. The magnetic controller and overall functional mechanism remain unchanged from the predicate device.

Test standards cited

IEC 62366-1 (human factors); ISO 10993-1 (biocompatibility); AAMI TIR35, ISO 11137-1, and ISO 11137-2 (sterilization); ASTM F2096 and ASTM F88 (packaging); ISO 14971:2019 (risk management). Real-time shelf-life testing and mechanical performance testing were also conducted.

Substantial equivalence argument

The expanded indications (grasping diaphragm and peripillar tissue in bariatric/hiatal hernia procedures) do not create new safety or effectiveness questions because they represent the same fundamental tissue-grasping and retraction function already cleared for the predicate device. A prospective 30-subject clinical study in Chile demonstrated zero serious adverse events and 100% technical success with no conversions or device malfunctions. The 12.5 cm tip and extended shelf life are minor technological refinements with no new or different risks identified through formal ISO 14971 risk assessment. Bench testing, biocompatibility, and sterilization validation all met acceptance criteria, confirming the device performs as intended and is therefore substantially equivalent to the predicate.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →